BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18288311)

  • 1. Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.
    Martin OV; Shialis T; Lester JN; Scrimshaw MD; Boobis AR; Voulvoulis N
    Environ Health Perspect; 2008 Feb; 116(2):149-57. PubMed ID: 18288311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.
    Martin O; Shialis T; Lester J; Scrimshaw M; Boobis A; Voulvoulis N
    Cien Saude Colet; 2008; 13(5):1601-18. PubMed ID: 18813661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis.
    Skakkebaek NE; Holm M; Hoei-Hansen C; Jørgensen N; Rajpert-De Meyts E
    APMIS; 2003 Jan; 111(1):1-9; discussion 9-11. PubMed ID: 12752226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis.
    Jørgensen N; Rajpert-De Meyts E; Main KM; Skakkebaek NE
    Int J Androl; 2010 Apr; 33(2):298-303. PubMed ID: 20132348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.
    Toppari J; Virtanen HE; Main KM; Skakkebaek NE
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):910-9. PubMed ID: 20865786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular dysgenesis syndrome: possible role of endocrine disrupters.
    Bay K; Asklund C; Skakkebaek NE; Andersson AM
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects.
    Sharpe RM; Skakkebaek NE
    Fertil Steril; 2008 Feb; 89(2 Suppl):e33-8. PubMed ID: 18308057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities.
    Gill WB; Schumacher GF; Bibbo M; Straus FH; Schoenberg HW
    J Urol; 1979 Jul; 122(1):36-9. PubMed ID: 37351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems.
    Wohlfahrt-Veje C; Main KM; Skakkebaek NE
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):459-65. PubMed ID: 19222487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity.
    Mahood IK; Scott HM; Brown R; Hallmark N; Walker M; Sharpe RM
    Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):55-61. PubMed ID: 18174951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism.
    Cederroth CR; Schaad O; Descombes P; Chambon P; Vassalli JD; Nef S
    Endocrinology; 2007 Nov; 148(11):5507-19. PubMed ID: 17673513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.
    Storgaard L; Bonde JP; Olsen J
    Reprod Toxicol; 2006 Jan; 21(1):4-15. PubMed ID: 16005180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate.
    Fisher JS; Macpherson S; Marchetti N; Sharpe RM
    Hum Reprod; 2003 Jul; 18(7):1383-94. PubMed ID: 12832361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.
    Virtanen HE; Rajpert-De Meyts E; Main KM; Skakkebaek NE; Toppari J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):501-5. PubMed ID: 16005920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are estrogens carcinogenic during development of the testes?
    McLachlan JA; Newbold RR; Li S; Negishi M
    APMIS; 1998 Jan; 106(1):240-2; discussion 243-4. PubMed ID: 9524585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
    Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
    Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a testicular dysgenesis syndrome exist?
    Akre O; Richiardi L
    Hum Reprod; 2009 Sep; 24(9):2053-60. PubMed ID: 19443456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'oestrogen hypothesis'- where do we stand now?
    Sharpe RM
    Int J Androl; 2003 Feb; 26(1):2-15. PubMed ID: 12534932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular dysgenesis syndrome.
    Skakkebaek NE
    Horm Res; 2003; 60 Suppl 3():49. PubMed ID: 14671395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environment, testicular dysgenesis and carcinoma in situ testis.
    Olesen IA; Sonne SB; Hoei-Hansen CE; Rajpert-De Meyts E; Skakkebaek NE
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):462-78. PubMed ID: 17875492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.